Factors influencing patient treatment selection among bispecific antibodies for relapsed/refractory multiple myeloma (RRMM): A mixed methods study
Conferences
LeBlanc, T; Popat, R; Kennedy, C; Coulter, J; Kopenhafer, L; You, W; Beusterien, K; Hughes, D; Nador, G; Cappelleri, JC; Dibonaventura, M ...
Published in: Blood
November 3, 2025
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 3, 2025
Volume
146
Issue
Supplement 1
Start / End Page
2631 / 2631
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
Citation
APA
Chicago
ICMJE
MLA
NLM
LeBlanc, T., Popat, R., Kennedy, C., Coulter, J., Kopenhafer, L., You, W., … Hlavacek, P. (2025). Factors influencing patient treatment selection among bispecific antibodies for relapsed/refractory multiple myeloma (RRMM): A mixed methods study. In Blood (Vol. 146, pp. 2631–2631). American Society of Hematology. https://doi.org/10.1182/blood-2025-2631
LeBlanc, Thomas, Rakesh Popat, C. Kennedy, Josh Coulter, Lewis Kopenhafer, William You, Kathleen Beusterien, et al. “Factors influencing patient treatment selection among bispecific antibodies for relapsed/refractory multiple myeloma (RRMM): A mixed methods study.” In Blood, 146:2631–2631. American Society of Hematology, 2025. https://doi.org/10.1182/blood-2025-2631.
LeBlanc T, Popat R, Kennedy C, Coulter J, Kopenhafer L, You W, et al. Factors influencing patient treatment selection among bispecific antibodies for relapsed/refractory multiple myeloma (RRMM): A mixed methods study. In: Blood. American Society of Hematology; 2025. p. 2631–2631.
LeBlanc, Thomas, et al. “Factors influencing patient treatment selection among bispecific antibodies for relapsed/refractory multiple myeloma (RRMM): A mixed methods study.” Blood, vol. 146, no. Supplement 1, American Society of Hematology, 2025, pp. 2631–2631. Crossref, doi:10.1182/blood-2025-2631.
LeBlanc T, Popat R, Kennedy C, Coulter J, Kopenhafer L, You W, Beusterien K, Hughes D, Nador G, Cappelleri JC, Dibonaventura M, Sumaya M, Hlavacek P. Factors influencing patient treatment selection among bispecific antibodies for relapsed/refractory multiple myeloma (RRMM): A mixed methods study. Blood. American Society of Hematology; 2025. p. 2631–2631.
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 3, 2025
Volume
146
Issue
Supplement 1
Start / End Page
2631 / 2631
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology